APA citáció

Szántó Kata Judit, Molnár Tamás, & Farkas Klaudia. (2018). New Promising Combo Therapy in Inflammatory Bowel Diseases Refractory to Anti-TNF Agents: Cyclosporine Plus Vedolizumab.

Chicago Style (17th ed.) Citation

Szántó Kata Judit, Molnár Tamás, and Farkas Klaudia. New Promising Combo Therapy in Inflammatory Bowel Diseases Refractory to Anti-TNF Agents: Cyclosporine Plus Vedolizumab. 2018.

MLA idézés

Szántó Kata Judit, et al. New Promising Combo Therapy in Inflammatory Bowel Diseases Refractory to Anti-TNF Agents: Cyclosporine Plus Vedolizumab. 2018.